All material subject to strictly enforced copyright laws. © 2022 IFLR is part of the Euromoney Institutional Investor PLC group.

Morrison & Foerster

The urgency for Japanese businesses to sell off non-core units due to corporate governance is creating opportunities for private equity
Fuelled by internal policies and the need to gain access to technology, healthcare and TMT will continue to be popular sectors that draw the most interest from Chinese investors
Faced with geopolitical tensions and heightened national security concerns on FDI, Chinese enterprises aspiring to go outwards will need to consider alternatives
Stringent disclosure requirements may make IPOs unviable for sensitive sectors anywhere but Hong Kong SAR may be an attractive venue due to higher thresholds for data reviews
Popular listing alternatives include re-listing elsewhere, going private and waiting to re-list in the US at a later point in time
Sources say that the curbs on retail investor participation would make Hong Kong SAR less competitive than Singapore and the US
While interest in the shell company process is growing in Asia, potential risks should not be forgotten
IFLR’s latest explainer looks at the new law, which will regulate the export of sensitive technologies from China